The $400 million US sales target is backed by niche products with average revenues of $5-7 million per product. For the ...

Strides also reduced its net debt by Rs 512.8 crore, bringing the net debt-to-EBITDA ratio down to 1.9x. The board ...

Strides Pharma Science Ltd on Wednesday reported ... announced a top management rejig with Executive Chairperson & Managing Director Arun Kumar designated as Executive Chairperson while Executive ...

Strides in Q4 delivers revenue at Rs. 1,190.4 crore, grew 17% YoY: Our Bureau, Bengaluru Thursday, May 22, 2025, 16:50 Hrs [IST] Strides Pharma Science in its consolidated financi ...

Strides Pharma Science reports multifold jump in Q4 profit to Rs 86.61 crore, driven by strong US business performance. Revenue also increased year-on-year.

Strides Pharma's revenue rose 14% on-year to ₹1,190 crore from last year's figure of ₹1,043.5 crore. Margins, however, ...

Watch Arun Kumar, Executive Chairperson, Strides Pharma Science Limited, on ET Now.#etnow #businessnews #sharemarket #englishnews #stridespharma #q1 #q1earnings #q1results #earningsupdate #growth ...

Strides Pharma Science Limited reported its ... an absolute gross margin increase of Rs 116.50 crore YoY. Arun Kumar, Founder, Executive Chairperson & Managing Director, said, “We are delighted ...

Stride Pharma Science Limited announced that its ... Commenting on the update, Arun Kumar, Founder, said, “The approval from EU-GMP is a significant stepping stone in our journey to build ...

Strides Pharma share price was ... and demerged into the structure,” Strides Pharma Science Executive Chairperson and Managing Director Arun Kumar said in a conference call.